Christina Mangurian, MD, MAS

Professor

Dr. Mangurian is a Professor of Clinical Psychiatry at UCSF School of Medicine and the UCSF Department of Psychiatry's Vice Chair for Diversity and Health Equity. Dr. Mangurian founded and directs the UCSF Program of Research on Mental health Integration among Underserved and Minority populations (PReMIUM) which is based at CVP (http://integration.ucsf.edu/).

Dr. Mangurian is a community psychiatrist whose NIH-funded research program focuses on improving diabetes screening and HIV care of people with severe mental illness (e.g., schizophrenia, bipolar disorder), particularly among underserved minority populations.

Dr. Mangurian has a successful track record in implementation in the public sector, most notably being her work as a Special Coordinator for the Medical Director of the New York State Office of Mental Health to implement health screening of 15,000 outpatients served within the New York State public mental health system (Mangurian et al., 2010). With her prior NIDDK-funded grant (Diabetes screening and care received by the mentally ill in an integrated system), Dr. Mangurian has partnered with Kaiser Permanente Northern California Division of Research to leverage Kaiser’s tremendous EHR to examine patient-, provider- and clinic-level variables that might influence diabetes care in this vulnerable population. Her current NIMH-funded R01 focuses on improving the HIV care of people with schizophrenia nationally.

In addition to her research experience, Dr. Mangurian is the Director and co-Founder of the UCSF Public Psychiatry Fellowship at San Francisco General Hospital. This was the first Public Psychiatry Fellowship in California, and the only one nationally to have a formal mental health services research component. Dr. Mangurian also serves as the Chair of the American Psychiatric Association’s Council on Minority Mental Health and Health Disparities.

Dr. Mangurian received her BA in Biology from Reed College. She graduated AOA from the UCSF School of Medicine, and completed her Psychiatry Residency and Chief Residency at Columbia University. She also completed the Columbia University Public Psychiatry Fellowship. Dr. Mangurian joined the faculty at UCSF Department of Psychiatry at Zuckerberg San Francisco General in 2009. She joined the faculty of the UCSF Center for Vulnerable Populations in 2014, and the faculty of the Philip R. Lee Institute for Health Policy Studies in 2018. She received a UCSF Master's Degree in Clinical Research, with Implementation Science Track coursework, in 2015.
Education
2017 - Diversity, Equity, and Inclusion Champion Training, University of California
MAS in Clinical Research, 2015 - Implementation Science Track, University of California, San Francisco
Residency, 2007 - Psychiatry, Columbia University
M.D., 2003 - Medicine, University of California, San Francisco
BA, 1996 - Biology, Reed College
Honors and Awards
  • UCSF Academic Senate Mentorship Award, UCSF, 2018
  • UCSF Chancellor's Award for the Advancement of Women, UCSF, 2017
  • UCSF Dean's Diversity Fund: John A. Watson Faculty Scholar, UCSF, 2015
  • Forum on Excellence and Innovation through Diversity in the STEM Workforce, White House, 2015
  • Early Career Women Faculty Professional Development Seminar Awardee, AAMC, 2010
Websites
Publications
  1. Parenting during Graduate Medical Training - Practical Policy Solutions to Promote Change.
  2. Peer Specialists in Community Mental Health: Ongoing Challenges of Inclusion.
  3. High Prevalence of Peripartum Depression Among Physician Mothers: A Cross-Sectional Study.
  4. TIME'S UP Healthcare: The Role of Mental Health.
  5. Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial.
  6. The Most Valuable Resource Is Time: Insights from a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities.
  7. Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population.
  8. Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics.
  9. TIME'S UP Healthcare: Can we put an end to gender inequality and harassment in medicine?
  10. Decisions and repercussions of second victim experiences for mothers in medicine (SAVE DR MoM).
  11. Patients as Perpetrators of Physician Sexual Harassment.
  12. Behavioral Health and Burnout Among Physician Mothers Who Care for a Person With a Serious Health Problem, Long-term Illness, or Disability.
  13. Physician mothers' experience of workplace discrimination: a qualitative analysis.
  14. Childbearing and Family Leave Policies for Resident Physicians at Top Training Institutions.
  15. Supporting caregivers during hematopoietic cell transplantation for children with primary immunodeficiency disorders.
  16. Alleviating the Mental Health Burden of Structural Discrimination and Hate Crimes: The Role of Psychiatrists.
  17. Psychosocial services for primary immunodeficiency disorder families during hematopoietic cell transplantation: A descriptive study.
  18. A Women's Health Clinic for a Safety-Net Inpatient Psychiatry Unit: Project PETIT.
  19. An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists.
  20. Paid Family and Childbearing Leave Policies at Top US Medical Schools.
  21. The need to support caregivers during pediatric bone marrow transplantation (BMT): A case report.
  22. A Doctor is in the House: Stakeholder Focus Groups About Expanded Scope of Practice of Community Psychiatrists.
  23. Utilization of the Behavior Change Wheel framework to develop a model to improve cardiometabolic screening for people with severe mental illness.
  24. Improving Breast Cancer Screening and Care for Women With Severe Mental Illness.
  25. Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study.
  26. Increasing HIV Testing in Inpatient Psychiatry.
  27. Mammography Among Women With Severe Mental Illness: Exploring Disparities Through a Large Retrospective Cohort Study.
  28. Understanding the Cost of a New Integrated Care Model to Serve CMHC Patients Who Have Serious Mental Illness.
  29. Contributions of immigrants to the field of US psychiatry.
  30. First-Episode Schizophrenia and Diabetes Risk.
  31. Perceived Discrimination Experienced by Physician Mothers and Desired Workplace Changes: A Cross-sectional Survey.
  32. Diabetes Prevalence Among Racial-Ethnic Minority Group Members With Severe Mental Illness Taking Antipsychotics: Double Jeopardy?
  33. Rates of Cervical Cancer Screening Among Women With Severe Mental Illness in the Public Health System.
  34. Implementation of a violence risk assessment tool on a safety-net inpatient psychiatry unit.
  35. Nonpsychiatric Outpatient Care for Adults With Serious Mental Illness in California: Who Is Being Left Behind?
  36. Patient-Centered Medical Care in Community Mental Health Settings.
  37. Low Rates of HIV Testing Among Adults With Severe Mental Illness Receiving Care in Community Mental Health Settings.
  38. Do Sugar-Sweetened Beverages Cause Obesity and Diabetes? Industry and the Manufacture of Scientific Controversy.
  39. Childhood Adversities Associated with Poor Adult Mental Health Outcomes in Older Homeless Adults: Results From the HOPE HOME Study.
  40. Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.
  41. Smartphone-Based Conversational Agents and Responses to Questions About Mental Health, Interpersonal Violence, and Physical Health.
  42. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers.
  43. Patient Factors Associated with Extended Length of Stay in the Psychiatric Inpatient Units of a Large Urban County Hospital.
  44. Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications.
  45. Behavioral strategies to mitigate violent behavior among inpatients: a literature review.
  46. The evolution of public psychiatry fellowships.
  47. The Systems SOAP Note: A Systems Learning Tool.
  48. Mental health services research training for the next generation of leaders in the public health sector: a case study of the UCSF/SFGH Public Psychiatry Fellowship.
  49. Descriptive analysis of a novel health care approach: reverse colocation-primary care in a community mental health "home".
  50. Food insecurity among adults with severe mental illness.
  51. The missing vital sign.
  52. Pop-up treatment plans for the urban psychiatric emergency room.
  53. Primary care providers' views on metabolic monitoring of outpatients taking antipsychotic medication.
  54. Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists.
  55. Public psychiatry fellowships: a developing network of public-academic collaborations.
  56. Implementation of a weight loss program for Latino outpatients with severe mental illness.
  57. Metabolic screening and treatment preferences of Hispanic inpatients.
  58. Points of contact: using first-person narratives to help foster empathy in psychiatric residents.
  59. State mental health policy: Physical health screening in state mental health clinics: the New York health indicators initiative.
  60. Risks from antipsychotic medications in children and adolescents.
  61. Obesity treatment for urban, low-income Latinos with severe mental illness.
  62. Improving support of residents after a patient suicide: a residency case study.
  63. Addressing cardiometabolic risk during treatment with antipsychotic medications.
  64. Late syphilis in a cardiac transplant patient.
  65. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland.
  66. Science in regulatory policy making: case studies in the development of workplace smoking restrictions.
  67. Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation.
  68. Expression of a Fas-like proapoptotic molecule on the lymphocytes of Xenopus laevis.
  69. Nephropathy in HIV-transgenic mice.